Recent Quotes (30 days)

You have no recent quotes
chg | %

Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 243   

Articles published

PFE 36.08 +0.25 (0.70%)
price chart
Pfizer gets its PILOT, will 'proceed aggressively' to next steps
Pfizer Inc. may have a 14-year job retention PILOT on lock, but it still needs to finalize a lease for its new East Memphis offices.
Pfizer's Big Deal Still Elusive as Company to Shed Consumer Unit
This isn't the first time the U.S.'s biggest drugmaker has flirted with breaking off parts of itself. In 2013, Pfizer spun out its animal health business into Zoetis Inc. through a stock offering, months after selling its infant nutrition business to ...
Pfizer ponders spinning off its Consumer Healthcare division  Proactive Investors UK
Pfizer reviewing alternatives for consumer healthcare business  Economic Times
Pfizer Inc. (PFE) Closes 1.02% Down on the Day for October 18
Shares of Pfizer Inc. (PFE) ended the trading day Wednesday at $35.83, representing a move of -1.02%, or $0.37 per share, on volume of 14.39 million shares.
Why Pfizer is set to land a $5.3 million local tax break — without building ...
Pfizer Inc., which has had Global Financial Services (GFS) operations located in Memphis since 2001, is in line to receive a $5.3 million, 14-year local tax break to keep those operations in Memphis from the Economic Development Growth Engine (EDGE ...
Pfizer, Amgen , Clovis Oncology and more - PRE-MARKET
Elsewhere, Clovis Oncology Inc (NASDAQ:CLVS) saw shares add 1.80% to US$83.50 after the bell, after it revealed that it had submitted a supplemental new drug application to the FDA for anti cancer agent rucaparib.
Bristol-Myers Squibb Company (BMY) vs. Pfizer Inc. (PFE)?: Which Should You ...
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) are both Healthcare companies that recently hit new highs.
Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company ...  Nasdaq
Why Investors remained confident on Diffusion Pharmaceuticals Inc. (DFFN ...
Pfizer Inc. (NYSE:PFE), at its latest closing price of $36.20, it has a price-to-book ratio of 0.00, compared to an industry average at 0.55.
In A First, Pfizer Spins Out Biotech Firm With $103 Million In Funding
Pfizer is announcing today that it is spinning out a new company, SpringWorks Therapeutics, to develop several drugs for rare diseases that the drug giant did not want to move forward internally.
Pfizer Spins Off New Firm for Some Rare Disease Drugs  Bloomberg
Pfizer tests new way to trial more drugs  Financial Times
Comprehensive Portfolio Management, LLC Buys PolarityTE Inc, Pfizer Inc, SPDR ...
Comprehensive Portfolio Management, LLC initiated holdings in PolarityTE Inc. The purchase prices were between $18.67 and $31.68, with an estimated average price of $24.34.
Pfizer: Growth Trajectory Locked, Ready For Launch
Pfizer underwent a period of revenue decline due to the loss of exclusivity on several of its blockbuster drugs. During this challenging period, Pfizer managed to maintain expenses under control and successfully develop its pipeline. The company is now ...